Stocks

Anthropic’s Claude tops OpenAI in Super Bowl ad engagement, EDO CEO Krim says – CNBC interview

Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.

“That money was intended for my children.”

“He charged $180 for the second visit for his time, including $40 for the part.”

Here are some other surprising facts and figures around Super Bowl LX.

Hims & Hers also said it’s selling a cancer-detection test that’s featured in its Super Bowl ad, which plays like a commentary on the wealthy’s access to better healthcare.

Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food and Drug Administration may weigh in on the side of the Danish drugmaker in…

Silver far outpaced gold’s decline on Thursday, with its sharp price losses leading to a turn lower for the week, even as gold looked to recover much of what it…

“Before you ask, there is nothing extreme about 5% of my ‘alternative’ assets.”

The largest part of the economy expanded again in January and pointed to decent growth early in the new year, as businesses grapple with the lingering effects of highs tariffs…